Don’t miss a thing! Sign up to get the latest announcements, important dates, and news.

News & Updates

COVID-19 Resources for the Endovascular Community

March 27, 2020

Guidance from Societies Guidelines & tools from the Society for Vascular Surgery Guidelines for vascular surgeons from The Vascular Society for Great Britain and Ireland COVID-19 and Cardiology from the European Society of Cardiology Clinical Guidance for Global Cardiovascular Clinicians from JACC Practice r ...

News & Updates

COVID-19 Update

March 23, 2020

VIVA is actively monitoring the effects of the COVID-19 pandemic. We continue our planning for VIVA20 and The VEINS in November; however, because this is an evolving situation, we will follow the CDC guidance closely to ensure the safety and health of faculty, attendees, exhibitors and staff. VIVA wishes our attendees ...

News & Updates

VIVA Board Members’ Latest Paper on Carotid Artery Stenting in Asymptomatic Carotid Artery Stenosis Published in JACC

February 20, 2020

VIVA Physicians, a leader in education and advocacy, convened a diverse coalition of stakeholders to address timely issues in peripheral arterial disease: care, reimbursement, and industry innovation. Stakeholders at the Vascular Leader’s Forum in Washington, DC, included representatives from major medical societies, U ...

News & Updates

Final Five Unpublished Late-Breaking Clinical Trial Results Announced at VIVA19

November 6, 2019

LAS VEGAS, 11/6/19 -- VIVA Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the final round of 21 highly anticipated late-breaking clinical trial results at VIVA19 hosted at Wynn Las Vegas. Below are highlights ...

News & Updates

New Round of Unpublished Clinical Trial Results Announced at VIVA19

November 6, 2019

LAS VEGAS, 11/6/19 -- VIVA Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the third round of 21 highly anticipated late-breaking clinical trial results at VIVA19 hosted at Wynn Las Vegas. Below are highlights ...

Load More